Having trouble accessing articles? Reset your cache.

Avastin bevacizumab regulatory update

The U.K.'s NICE issued a second preliminary appraisal recommending against the use of Roche's Avastin bevacizumab in combination with oxaliplatin and either 5-fluorouracil plus folinic acid

Read the full 269 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE